Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

348 results about "Non covalent" patented technology

A non-covalent interaction differs from a covalent bond in that it does not involve the sharing of electrons, but rather involves more dispersed variations of electromagnetic interactions between molecules or within a molecule.

Epidermal growth factor connecting polypeptide and application thereof in endometrial injury repair

The invention belongs to the technical field of biological medicines, and particularly discloses an epidermal growth factor-linker polypeptide-collagen, and the linker polypeptide has an amino acid sequence as shown in SEQ ID No.1. The linker polypeptide capable of connecting the EGF and the collagen is designed and synthesized, the N end of the linker polypeptide simulates an EGF receptor structure and can be combined with the EGF, and the linker polypeptide is connected with the EGF through non-covalent Van der Waals force, so that the structure of the EGF cannot be damaged; the C terminal of the linker polypeptide is rich in lysine residues, and can be covalently crosslinked to collagen through glutamine transaminase to form EGF-linker polypeptide-collagen. The protein solution taking EGF-linker polypeptide-collagen as active ingredients is low in cytotoxicity and high in biological safety, and meanwhile, the action time of the epidermal growth factor can be remarkably prolonged. In addition, a stable repairing microenvironment can be formed on the surface of the endometrium, and the endometrium injury repairing effect is remarkably improved.
Owner:SHOUXI (GUANGZHOU) MEDICAL TECH CO LTD

Injectable hydrogel capable of rapidly stopping bleeding and preparation method thereof

The invention discloses injectable hydrogel capable of rapidly stopping bleeding and a preparation method thereof. The injectable hydrogel is prepared from a natural high-molecular compound, a natural high-molecular polymer, an organic high-molecular polymer, a catechol-like organic compound, a cross-linking agent and ultrapure water. A natural high-molecular linear polymer is combined with an organic high-molecular polymer in a non-covalent bond manner to form a macromolecular polymer, and the macromolecular polymer is used as a main network skeleton of the hydrogel to provide strength support; the catechol-like organic compound and the natural high-molecular compound form a strong non-covalent effect in a polymer chain to enhance the strength, the hemostatic property, the antibacterial property, the adhesion and the self-healing property of the organogel; besides, under the action of the cross-linking agent, the catechol-like organic compound forms a free radical group to be subjected to free radical coupling with the macromolecular polymer, so that the effect of enhancing a hydrogel network is achieved, and meanwhile, hydrogen bonds, dipole-dipole interaction, static interaction and the like can be formed with polar functional groups on the surface. The hemostatic gel is rapid in hemostasis, simple to prepare, good in biocompatibility, good in antibacterial property, injectable and degradable.
Owner:NORTHWEST UNIV

Room-temperature self-repairing thermosetting polymer material and preparation method thereof

ActiveCN118994538APolymer scienceMeth-
The invention discloses a room-temperature self-repairing thermosetting polymer material and a preparation method thereof, and the raw materials of the room-temperature self-repairing thermosetting polymer material comprise 2-amino-4-hydroxy-6-methylpyrimidine, hexamethylene diisocyanate, polyethyleneimine, and 1, 2-cyclohexanedicarboxylic acid diglycidyl ester. A double-dynamic crosslinking strategy is used, namely covalent crosslinking guarantees high strength, high rigidity and high solvent resistance of thermosetting macromolecules, non-covalent crosslinking can improve the toughness of the material and endow the material with the room-temperature self-repairing characteristic, and the epoxy curing agent UNP which has high-motility branched chains and can form high-density hydrogen-bond interaction is designed and synthesized; and curing and cross-linking an epoxy monomer DCN containing an ester group structure to obtain the glassy thermosetting polymer material UNP-DCN with a room-temperature self-repairing function. The material has glass transition temperatures (Tg1 = 16 DEG C and Tg2 = 106 DEG C) in two different temperature intervals, and shows relatively high room-temperature self-repairing capability.
Owner:CHONGQING UNIV

Tetrahedral antibodies

This invention provides a tetrahedral antibody comprising a first, second, third, and fourth domain, wherein the first and second domains are Fab or Fc domains; wherein each of the first and second domains comprise a first polypeptide chain comprising a first N-terminus of the domain, and a second polypeptide chain comprising a second N-terminus of the domain; wherein the first N-terminus of the first domain and the first N-terminus of the second domain are joined to each other by a non-peptidyl linkage, which can be a covalent linkage or a non-covalent linkage between first and second dimerizing polypeptides attached to the first N-termini of the first and second domains, respectively; and wherein the third and fourth domains are attached at their respective C-termini to the second N-termini of the first and second domains, respectively, or the N-termini of the first and second dimerizing polypeptides.
Owner:BIOMOLECULAR HOLDINGS LLC

Preparation method and application of recombinant XVII type collagen and adenosine eutectic

The invention discloses a preparation method and application of a recombinant XVII type collagen and adenosine eutectic substance. According to the invention, adenosine and recombinant XVII type collagen are combined through a non-covalent bond to form a novel supramolecular eutectic substance. The solubility and skin permeability of the eutectic substance are improved through the synergistic effect of the two substances, and the performance of fixing hair and promoting hair papilla cell proliferation is also enhanced.
Owner:JIANGNAN MEIWAN (WUXI) HEALTH TECHNOLOGY CO LTD

Boronic acid compositions and methods for tethering ribonucleic acids in biological samples

The present disclosure relates in some aspects to methods and boronic acid compositions for immobilizing RNA analytes in biological samples, and more specifically fragmented RNAs. RNA analytes may be tethered covalently or non-covalently to exogenous or endogenous molecules in a biological sample, for example, cross-linked directly to a polymerized three-dimensional matrix.
Owner:10X GENOMICS INC

Lipid nanoparticle with non-covalent bifunctional binders for active targeting

A nanoparticle complex comprises a bifunctional binder capable of non-covalently binding to the lipid nanoparticle in the nanoparticle complex.
Owner:MOTE THERAPEUTICS INC +1

Organic solar cell based on halogenated additive and preparation method thereof

The invention relates to the technical field of preparation of organic solar cells, in particular to an organic solar cell based on a halogenated additive, and the structure level of a forward device of the solar cell sequentially comprises a transparent conductive substrate, a hole transport layer, an organic active layer, an electron transport layer and a metal electrode from bottom to top, the organic active layer comprises a polymer donor PM6, a non-fullerene electron acceptor L8-BO and a halogenated additive DFBB. Through addition of a halogenated additive DFBB, strong non-covalent bonding is formed by unique sigma-hole interaction of the halogenated additive DFBB and a receptor L8-BO, and meanwhile, the molecular stacking orientation of the active layer can be accurately regulated and controlled by the polymer electrostatic potential extreme value of the halogenated additive DFBB. The halogenated additive DFBB preferentially generates strong sigma-hole interaction with acceptor molecules, ordered accumulation of L8-BO is remarkably enhanced, meanwhile, the crystallization behavior of the donor PM6 is balanced through the synergistic halogen effect, a bicontinuous interpenetrating network structure is formed, and the photo-generated exciton yield is improved.
Owner:SHANGHAI SECOND POLYTECHNIC UNIVERSITY

Bioactive conductive hydrogel as well as preparation method and application thereof

The invention provides bioactive conductive hydrogel as well as preparation and application thereof. The hydrogel comprises a dynamic non-covalent cross-linked network which is composed of natural macromolecules and at least comprises a reversible and environment-responsive cross-linking mode; the responsive conductive component is connected with the dynamic non-covalent cross-linked network through a covalent bond or a coordinate bond, the electrical property of the responsive conductive component changes along with the change of the wound surface microenvironment, and electrical signal feedback of the wound surface state is provided through the change of the electrical property; and the active substance is connected to the dynamic non-covalent cross-linked network through a responsive chemical bond, and the responsive chemical bond is broken under specific conditions of a wound surface microenvironment to release the active substance. Compared with the prior art, the integrated design of active oxygen monitoring and drug release is realized for the first time, the wound healing time (about 30-40%) can be remarkably shortened, the complication risk is reduced, and an innovative solution is provided for wound management in an intelligent medical mode.
Owner:SHANDONG UNIV

Oligonucleotide nano delivery system based on polypeptide modification and application thereof

The invention discloses an oligonucleotide intracellular nano delivery system based on polypeptide modification and application thereof. The system is composed of a periostin targeting sequence (SDSSD), a matrix metalloproteinase 2 (MMP2) response sequence (GPAGLLG), a cell penetrating sequence (RRRRRRRR, R9), a reactive oxygen species (ROS) scavenging and adhesion enhancing group (Gly-DOPA)) and a terminal dibenzocyclooctyne (DBCO) modified engineered polypeptide SDSSD-PEG5-YGFGG-GPAGLLG-R9-(G-DOPA) 3-K4-C-DBCO, and a target oligonucleotide miRNA-26a-A5-Azido modified by 5-polyadenylic acid (AAAAA) and an azide group (Azido), and the target oligonucleotide miRNA-26a-A5-Azido, the target oligonucleotide and assembling through a click chemical reaction and a non-covalent interaction. The nano system has good bone targeting, enzyme responsiveness, intracellular delivery effect and biological safety, can realize stable and efficient delivery of therapeutic oligonucleotides in vivo, and significantly improves the utilization efficiency and therapeutic potential of oligonucleotides. The oligonucleotide intracellular nano delivery system has a wide application prospect in the fields of clinical transformation and precise treatment of oligonucleotide drugs.
Owner:THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIV

Salicylic acid-cyclodextrin-amino acid ternary inclusion compound as well as preparation method and application thereof

The invention discloses a salicylic acid-cyclodextrin-amino acid ternary inclusion compound and a preparation method thereof. The salicylic acid-cyclodextrin-amino acid ternary inclusion compound is formed by salicylic acid, amino acid and a cyclodextrin derivative through non-covalent bond interaction, the cyclodextrin derivative is a cross-linked beta-cyclodextrin polymer, salicylic acid molecules are included in a cavity of the cross-linked beta-cyclodextrin polymer, and the cross-linked beta-cyclodextrin polymer is a cross-linked beta-cyclodextrin polymer. And meanwhile, guanidyl or carboxyl of an amino acid side chain interacts with hydroxyl outside the cross-linked beta-cyclodextrin polymer or an exposed part of an included salicylic acid molecule. According to the invention, a cross-linked beta-cyclodextrin polymer is used, arginine is introduced as a synergist, a salicylic acid-cross-linked beta-cyclodextrin polymer-arginine ternary clathrate compound is constructed, and through charge neutralization and hydrogen bond network synergistic effect, clathration efficiency is significantly improved, and water solubility of salicylic acid is improved.
Owner:AIXIMEI (ZHUHAI) BIOTECHNOLOGY CO LTD

Preparation method and application of chitosan-casein peptide nanocomposite

The invention discloses a chitosan-casein peptide nano-particle and a preparation method and application thereof, and belongs to the technical field of food manufacturing, chitosan and casein peptide are combined into a nano-composite with the particle size of 10-1000 nm through electrostatic interaction in a non-covalent binding mode, and the nano-composite is used for preparing the chitosan-casein peptide nano-particle. A more stable oil-in-water emulsion can be prepared by utilizing the nano composite; the invention also provides a preparation method and application of the chitosan-casein peptide nanocomposite, and a preparation method of the oil-in-water emulsion. The nano-composite prepared by the invention has relatively strong oxidation resistance, foamability and foaming stability when the ratio of chitosan to casein peptide is 1: 1, and an oil-in-water emulsion prepared from the nano-composite has good storage stability, pH stability and ion stability. The preparation method of the nanocomposite is simple and low in cost, and has a good application prospect.
Owner:NORTHEAST AGRICULTURAL UNIVERSITY

Preparation method and application of multifunctional agarose-based particle composite hydrogel based on liquid-liquid phase separation

The invention is applicable to the technical field of polymer biomedical hydrogel materials, and provides a preparation method and application of multifunctional agarose-based particle composite hydrogel based on liquid-liquid phase separation, and the agarose-based particle composite hydrogel is a product formed by introducing microsphere particles into an agarose hydrogel body matrix; the microsphere particles are formed by a prepolymer and sodium lignin sulfonate through phase separation mediated by a composite behavior based on non-covalent interaction; the prepolymer is obtained by carrying out amine-epoxy reaction on an amino compound and an epoxy compound in water. According to the prepared agarose-based particle composite hydrogel, a microsphere particle structure is formed on the surface of an agarose matrix while positively charged amino groups and sodium lignin sulfonate are introduced, so that the multifunctional agarose-based particle composite hydrogel is prepared.
Owner:LIAONING NORMAL UNIVERSITY

Nanomaterial delivery carriers and methods of use thereof

The self-assembled nano material comprises a Janus-based nano tube, wherein the Janus-based nano tube comprises at least one compound represented by a formula I to a formula XII, or a pharmaceutically acceptable salt of the compound. Also described are compositions comprising the Janus-based nanotubes, comprising a biologically active molecule covalently or non-covalently attached to the self-assembled nanomaterial.
Owner:UNIV OF CONNECTICUT

Injectable hydrogel as well as preparation method and application thereof

The invention discloses injectable hydrogel as well as a preparation method and application thereof. The hydrogel is a chemical-physical double-network cross-linked hydrogel prepared from a blended solution with magnesium acrylate, carboxymethyl chitosan and phytic acid as main components. Wherein covalent cross-linking is derived from a magnesium polyacrylate network constructed by free radical polymerization reaction. Non-covalent cross-linking is derived from hydrogen bonds and electrostatic interaction among components in an interpenetrating network and a carboxymethyl chitosan chain entanglement network formed by gradual induction in the application process of a physiological environment. In the preparation process, the pH value of a reaction system is controlled by controlling the concentration of phytic acid, magnesium ions are chelated, then the structural strength of the hydrogel is controlled, and the injectable effect is achieved. Meanwhile, phytic acid can be chelated with protein, so that the adhesion of the phytic acid to tissues is enhanced. The preparation process is simple and convenient, easy to control and suitable for large-scale industrial production, and all the raw materials are easy to obtain and low in price. The hydrogel has high adhesion efficiency and wet adhesion strength to tissue.
Owner:SOUTHEAST UNIV +1

Composite modified beta-lactoglobulin as well as preparation method and application thereof

The invention discloses composite modified beta-lactoglobulin as well as a preparation method and application thereof. The preparation method comprises the following steps: dissolving beta-lactoglobulin powder in deionized water to form a beta-lactoglobulin solution; the preparation method comprises the following steps: sequentially carrying out microjet treatment and succinylation treatment to obtain microjet-assisted acylated beta-lactoglobulin, then dialyzing the acylated beta-lactoglobulin solution for purification treatment, and finally freeze-drying to obtain the composite modified acylated beta-lactoglobulin powder. The beta-lactoglobulin is subjected to composite modification by fusing microjet and succinylation, the compact structure of the protein is expanded by the microjet, reaction active sites in the protein are exposed, the solubility of the protein is improved, and meanwhile, convenience is provided for subsequent chemical modification by breakage of non-covalent bonds. The introduction of the succinyl group adjusts the surface property of the protein and improves the emulsifying property of the beta-lactoglobulin. And meanwhile, the oxidation resistance of the beta-lactoglobulin is enhanced due to the oxidation resistance of the succinyl.
Owner:ZHEJIANG UNIV OF TECH

Nucleotide-modified covalent G4 DNA enzyme, preparation method thereof and application of nucleotide-modified covalent G4 DNA enzyme in in-vitro diagnosis

The invention belongs to the technical field of biology, and particularly discloses a nucleotide-modified covalent G4DNA enzyme, a preparation method thereof and application of the nucleotide-modified covalent G4DNA enzyme in in-vitro diagnosis. The enzyme comprises Hemin, ligand nucleotide and a G4 structure which are covalently combined in sequence through an amidation reaction, the ligand nucleotide is modified at the 3'end and / or the 5 'end of the G4 structure and comprises 1-3 basic groups, and the basic groups are selected from at least one of adenine, thymine and cytosine. The nucleotide modified covalent G4DNA enzyme disclosed by the invention shows catalytic capability equivalent to that of HRP (horse radish peroxidase) no matter in homogeneous phase or localized liquid drops, and the catalytic performance of the nucleotide modified covalent G4DNA enzyme is superior to that of traditional G4 / Hemin DNA enzyme and non-covalent G4DNA enzyme; in addition, the compound also has strong environmental tolerance and weak metal ion dependence, is simple to synthesize and convenient to store, and has huge in-vitro diagnosis application potential.
Owner:THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY

Cationic tannin and prolamin composite nano system as well as preparation method and application thereof

The invention relates to a cationic tannin and prolamin composite nano system and a preparation method and application thereof.The cationic tannin and prolamin composite nano system is prepared through the steps that cationic tannin and prolamin are dissolved in an alcoholic solution through an anti-solvent dispersion method, then the alcoholic solution is dropwise added and dispersed in water, and the cationic tannin and prolamin composite nano system is obtained. Nano-particles are formed through self-assembly under the interaction of non-covalent acting force between cationic tannin and prolamin in an aqueous solution, and the composite nano-system is applied to water treatment. Compared with the prior art, the water treatment agent is good in storage stability and has excellent performance of removing antibiotic pollution in a water body.
Owner:SHANGHAI UNIV OF MEDICINE & HEALTH SCI

Janus hydrogel with lasting wet tissue adhesion and abdominal adhesion resistance

The invention discloses Janus hydrogel with lasting wet tissue adhesion and abdominal adhesion resistance. The Janus hydrogel consists of an adhesion layer AL and an anti-adhesion layer AAL, the preparation method is simple, efficient and low in cost. For the adhesion layer AL, firm adhesion is formed on a moist tissue through the synergistic effect of covalent bonds of non-covalent and NHS groups, and the tridentate hydrogen bond of APMA-co-THMA provides a lasting and strong adhesion effect for AL. And the anti-adhesion layer ALL utilizes the hydrophilicity of zwitterions so as to realize the anti-biological adhesion characteristic. Therefore, the hydrogel patch prepared by the invention has proper biocompatibility, and also has excellent adhesion and anti-adhesion effects. Wide application prospects are realized in the field of biomedical materials.
Owner:NINGBO MEDICAL CENT LIHUILI HOSPITACL

Asymmetric gemini-like surfactant constructed based on non-covalent bonds as well as preparation method and application of asymmetric gemini-like surfactant

The invention discloses an asymmetric gemini-like surfactant constructed based on non-covalent bonds as well as a preparation method and application of the asymmetric gemini-like surfactant, and belongs to the technical field of fire-fighting foam extinguishing agents. The preparation method comprises the following steps: mixing medium-chain fatty acid and polyether amine D230 according to a certain molar ratio in a nitrogen atmosphere, heating in a water bath to a reaction temperature, fully stirring for 15 minutes, and constructing through a non-covalent bond to obtain an intermediate; and adding long-chain fatty acid into the intermediate according to a certain molar ratio, keeping the reaction temperature, continuously stirring for 15 minutes, obtaining a product through non-covalent bond construction, and carrying out vacuum drying for more than 12 hours to obtain the asymmetric gemini-like surfactant. The prepared asymmetric gemini-like surfactant has the advantages of being high in foaming capacity, long in half-life period and low in surface tension, and is suitable for replacing a fluorocarbon surfactant to be used as a foaming agent in an environment-friendly foam extinguishing agent.
Owner:CHINA UNIV OF PETROLEUM (EAST CHINA)

Physical cross-linked network composite material loaded with acellular matrix particles

The invention relates to a physical cross-linked network composite material loaded with acellular matrix particles, and belongs to the technical field of biomedical materials. According to the invention, acellular matrix particles are uniformly embedded and loaded by using a high-molecular polymer system such as alginate, and three metal ion introduction modes can be selected to form a physical cross-linked structural framework mainly depending on the characteristic that alginate and metal cations are easy to be subjected to ionic cross-linking; on the basis, other high-molecular polymers can be further introduced. Through crosslinking of various non-covalent bonds between polymers and metal ions and between the polymers, the polymers in the system are interspersed and wound to form a semi-interpenetrating and interpenetrating polymer three-dimensional network structure, so that the network composite material loaded with acellular matrix particles is obtained.
Owner:SHANGHAI BAIYIYUAN BIOENGINEERING CO LTD

A glycyrrhizin-based composite of bosine and collagen nanoparticles, its preparation method and application

This invention belongs to the field of cosmetic technology, specifically a glycyrrhizin-based composite nanoparticle containing sclerotherapy, BPOXY, and collagen, along with its preparation method and applications. The invention first combines glycyrrhizin and glycyrrhizic acid via non-covalent bonds to obtain a glycyrrhizin-glycyrrhizic acid eutectic structure that overcomes the solubility problem of glycyrrhizin. Then, a BPOXY-collagen mixture is used to coat the glycyrrhizin-glycyrrhizic acid eutectic structure, yielding glycyrrhizin-based composite nanoparticles containing sclerotherapy, BPOXY, and collagen. The glycyrrhizin-based composite nanoparticles containing sclerotherapy, BPOXY, and collagen obtained using this method exhibit good water solubility of glycyrrhizin, a simple composition, high stability, and minimal risk of allergic reactions. Furthermore, it enhances the skin permeability of glycyrrhizin, collagen, and BPOXY, resulting in a synergistic effect and improved bioavailability.
Owner:GUANGZHOU PINYU BEAUTY INNOVATION TECH CO LTD +1

A thiosericin-based active molecular probe based on AfBPP and its preparation and application

This invention discloses an AfBPP-based active molecular probe for thiostreptin, its preparation, and its application, belonging to the field of chemical biology. This invention introduces a bifunctional tag integrating a photocrosslinking group (bisacrididine) and a bioorthogonal reactive group (alkynyl group) into the structure of thiostreptin. While retaining the original biological activity of the parent compound, it endows the probe with highly efficient probe function, solving the technical problem of target loss during washing and purification of traditional non-covalent probes. After target labeling, the probe can specifically connect to reporter groups such as fluorescein or biotin through click-chemical reactions, achieving efficient enrichment of drug targets. Combined with mass spectrometry analysis, it enables global identification of potential targets in cells or complex biological samples at the omics level, such as chemical proteomics, providing a powerful molecular tool for in-depth revelation of the potential targets and pharmacological mechanisms of thiostreptin.
Owner:SHENZHEN TECH UNIV

Novel interleukin-15 (IL-15) fusion protein and its use

The present disclosure provides novel and improved IL-15 fusion proteins for treating cancer and other disorders. In various embodiments, the fusion protein of the present invention has two functional domains: an IL-15 / IL-15RαSushi domain (also referred to herein as "IL-15 / IL-15RαSushi complex") and an Fc domain, each of which can take different forms and is configured so that IL-15 is fused to the C-terminus of the Fc domain and co-expressed and non-covalently complexed with IL-15RαSushi. Importantly, the fusion protein of the present invention solves several defects observed in the IL-15 therapeutic agents evaluated to date; specifically, the fusion protein shows an extended half-life of IL-15 in vivo and exhibits better preclinical activity than rIL-15 or related cytokine therapeutics.
Owner:CUGENE INC

Glucocorticoid-baicalein and / or baicalin co-amorphous substance and application thereof

The invention discloses a glucocorticoid-baicalein and / or baicalin co-amorphous substance and application thereof.The co-amorphous substance is formed by glucocorticoid, baicalein and / or baicalin in a non-covalent bond mode, the molar ratio of glucocorticoid to baicalein and / or baicalin is 1: 10-10: 1, powder X-ray diffraction analysis of CuK alpha radiation is adopted, and by taking 2 theta as the unit, the ratio of the glucocorticoid to the baicalein to the baicalein is 1: 10-1: 1. A powder X-ray diffraction pattern of the co-amorphous substance has a dispersion diffraction peak at a position of 15.0 + / -0.3 degrees to 27.0 + / -0.3 degrees. According to the application, glucocorticoid is combined with baicalein and / or baicalin according to a specific proportion, so that the pharmaceutical composition is used for treating or preventing thymoma. The composition is prepared by a mechanochemical method, forms a co-amorphous substance, and has the potential of improving the solubility of the medicine and improving the curative effect. Besides, the pharmaceutical composition can be prepared into various dosage forms, is convenient for clinical application, provides a new treatment choice for treating the thymoma, and particularly has remarkable clinical significance for patients with poor traditional treatment effects.
Owner:BEIJING TONGREN HOSPITAL AFFILIATED TO CAPITAL MEDICAL UNIV +1

Methods for Nucleic Acid Cleavage

PendingUS20240417778A1Microbiological testing/measurementNucleic acid cleavageCovalent modifier
The invention provides a method for cleaving a target nucleic acid molecule. The method comprises contacting the target nucleic acid molecule with a bifunctional molecule of formula (I), C-L-B, where —C is a cleavage group that is imidazole, optionally substituted with 1 to 3 C1-6 alkyl groups, -L- is a linker and —B is a non-covalent binding group, such that the bifunctional molecule non-covalently binds to the target nucleic acid molecule, and allowing the bifunctional molecule to cleave the target nucleic acid molecule bound thereto. The invention also provides a method of identifying a secondary or tertiary structure within a target nucleic acid, as well as a bifunctional molecule and a bifunctional molecule for use in a method of treatment.
Owner:CAMBRIDGE ENTERPRISE LTD

Chrysin and piperazine eutectic, and preparation method, composition and application thereof

The invention belongs to the technical field of medicines, and discloses a chrysin and piperazine eutectic, a preparation method, a composition and application thereof. Specifically, the invention discloses an eutectic substance formed by combining chrysin and piperazine through a non-covalent bond, and the molecular formula of the eutectic substance is (C15H10O4). (C4H10N2) 0.5, the invention relates to a preparation method of a chrysin and piperazine eutectic. The chrysin and piperazine eutectic is applied to preparation of drugs with the effects of preventing and treating cardiovascular diseases, resisting oxidation, resisting cancer, resisting virus, resisting hypertension, reducing blood fat, reducing blood sugar, resisting bacteria, diminishing inflammation and the like.
Owner:INST OF MATERIA MEDICA CHINESE ACAD OF MEDICAL SCI

Albumin-based non-covalent complexes and methods of use thereof

A non-covalent complex of an albumin molecule and a hydrophobic ligand, compositions containing the same, and methods of use thereof are provided. The present complex may find use in delivering the hydrophobic ligand to microorganisms that have albumin-binding outer surfaces, such as a cell wall.
Owner:SPECTRAL PLATFORMS INC

A self-healing elastomer based on imidazole urea bond coordinated by copper ions

The present invention relates to a self-healing elastomer based on imidazole urea bond coordinated by copper ions. The structural formula of the self-healing elastomer is (Ⅰ), (Ⅱ) or (Ⅲ). The self-healing elastomer is constructed by a Cu-BIMU locking unit coupled with a new dynamic imidazole urea bond and multiple non-covalent bonds. Cu-BIMU concentrates quadruple dynamic bonds in one locking unit instead of forming covalent or non-covalent cross-linking bonds that are usually independent of each other, so as to avoid forming too many apparent cross-linking sites, thereby ensuring the high fluidity of the polymer chain. At the same time, the coupled quadruple dynamic bonds construct an ultra-strong Cu-BIMU unit, while showing high comprehensive bond energy and reversibility, which helps to solve the long-standing contradiction between the high tensile strength and self-healing performance of the material.
Owner:DONGHUA UNIV